These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2963691)
1. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma. Chisesi T; Capnist G; Vespignani M; Dini E Cancer Treat Rev; 1988 Jan; 15 Suppl A():27-33. PubMed ID: 2963691 [No Abstract] [Full Text] [Related]
2. A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy. Clark RH; Dimitrov NV; Axelson JA; Charamella LJ; Stott PB Am J Clin Oncol; 1989 Feb; 12(1):75-7. PubMed ID: 2912022 [TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma. Chisesi T; Capnist G; Vespignani M; Cetto G Invest New Drugs; 1987; 5 Suppl():S35-40. PubMed ID: 3298132 [TBL] [Abstract][Full Text] [Related]
5. [Therapy with alpha-interferon in non-Hodgkin's lymphoma with a low grade of malignancy (correct title supplied from Table of Contents)]. Chisesi T Haematologica; 1990; 75 Suppl 4():72-7. PubMed ID: 2074057 [No Abstract] [Full Text] [Related]
6. Ongoing studies on non-Hodgkin's lymphomas (NHL) within the EORTC lymphoma group. Tirelli U Leukemia; 1991; 5 Suppl 1():105-6. PubMed ID: 1890859 [No Abstract] [Full Text] [Related]
7. High-dose chlorambucil and dexamethasone for relapsed non-Hodgkin's lymphomas. Joseph G; Hadley T; Djulbegovic B; Hamm J; Seeger J; Blumenreich M; Woodcock T Am J Clin Oncol; 1993 Aug; 16(4):319-22. PubMed ID: 8328409 [TBL] [Abstract][Full Text] [Related]
8. Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma. Martinelli G; Laszlo D; Bertolini F; Pastano R; Mancuso P; Calleri A; Vanazzi A; Santoro P; Cavalli F; Zucca E Br J Haematol; 2003 Oct; 123(2):271-7. PubMed ID: 14531908 [TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory low grade lymphoma with chlorambucil alternating with interferon and radiotherapy. Avilés A; Talavera A; Guzmán R; Cuadra I Cancer Biother; 1995; 10(4):273-7. PubMed ID: 8590892 [TBL] [Abstract][Full Text] [Related]
10. Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma. Leavitt RD; Ratanatharathorn V; Ozer H; Ultmann JE; Portlock C; Myers JW; Kisner D; Norred S; Spiegel RJ; Bonnem EM Semin Oncol; 1987 Jun; 14(2 Suppl 2):18-23. PubMed ID: 3589702 [No Abstract] [Full Text] [Related]
11. Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma. Ozer H; Anderson JR; Peterson BA; Budman DR; Henderson ES; Bloomfield CD; Gottlieb A Invest New Drugs; 1987; 5 Suppl():S27-33. PubMed ID: 3298131 [TBL] [Abstract][Full Text] [Related]
12. Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma. VanderMolen LA; Steis RG; Duffey PL; Foon KA; Smith JW; Clark JW; Conlon K; Stevenson HC; Urba WJ; Hartmann LC J Natl Cancer Inst; 1990 Feb; 82(3):235-8. PubMed ID: 2296053 [No Abstract] [Full Text] [Related]
13. Non-Hodgkin's lymphoma presenting at the site of a recent dental extraction: a report of two cases. Thomas DW; Gray W; Tate RJ Br J Oral Maxillofac Surg; 1991 Feb; 29(1):34-7. PubMed ID: 2004074 [TBL] [Abstract][Full Text] [Related]
14. Clinical use of interferon alfa-2b (intron-A): the Manchester experience. Scarffe JH; Wagstaff J; Crowther D Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285 [No Abstract] [Full Text] [Related]
15. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. Conlan MG; Bast M; Armitage JO; Weisenburger DD J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234 [TBL] [Abstract][Full Text] [Related]
16. [A preliminary study of chemo-interferon therapy in malignant lymphoma]. Takeyama H; Yano K; Fukutani H; Watanabe E Gan To Kagaku Ryoho; 1987 Jan; 14(1):140-5. PubMed ID: 3800402 [TBL] [Abstract][Full Text] [Related]
17. Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin. Von Hoff DD; Sarosy G; Brown TD; Kuhn JG; Kisner DL Semin Oncol; 1986 Sep; 13(3 Suppl 2):72-7. PubMed ID: 3764442 [TBL] [Abstract][Full Text] [Related]
18. [Low-grade non-Hodgkin's lymphoma in the adult: new therapeutic approaches]. Gisselbrecht C; Lepage E; Sebban C; Coiffier B Nouv Rev Fr Hematol (1978); 1987; 29(1):77-81. PubMed ID: 2438647 [TBL] [Abstract][Full Text] [Related]
19. Multilobated non-Hodgkin lymphoma of B-cell type: leukemization and multiorganic involvement. Millá F; Juncà J; Flores A; Lorenzo JC; Andreu J; Navas JJ Am J Hematol; 1989 Dec; 32(4):311-3. PubMed ID: 2816926 [TBL] [Abstract][Full Text] [Related]
20. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma. Steis RG; Foon KA; Longo DL Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]